Relay Therapeutics (RLAY) Revenue (2021 - 2026)
Relay Therapeutics (RLAY) posted quarterly Revenue of $3.0 million for Q1 2026, down 60.93% year-over-year from $7.7 million in Q1 2025, and down 57.14% quarter-over-quarter from $7.0 million in Q4 2025.
Relay Therapeutics (RLAY) Revenue (2021 - 2026) Analysis & Trends
Relay Therapeutics (RLAY) has reported Revenue for 6 consecutive years, with $3.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Revenue fell 60.93% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $10.7 million (up 39.04% YoY), while the FY2025 annual figure was $15.4 million, up 53.44% from the prior year.
- Revenue declined to $3.0 million in Q1 2026 per RLAY's latest filing, from $7.0 million in the prior quarter.
- Across five years, Revenue topped out at $25.2 million in Q3 2023 and bottomed at -$1000.0 in Q4 2023.
- Historically, Revenue has averaged $4.3 million across 5 years, with a median of $419000.0 in 2022.
- On a YoY basis, Revenue climbed as much as 7226.16% in 2023 and fell as far as 100.4% in 2023.
- Relay Therapeutics' Revenue stood at $253000.0 in 2022, then slumped by 100.4% to -$1000.0 in 2023, then soared by 1000800.0% to $10.0 million in 2024, then plunged by 30.05% to $7.0 million in 2025, then sank by 57.14% to $3.0 million in 2026.
- Business Quant data shows RLAY's Revenue at $3.0 million in Q1 2026, $7.0 million in Q4 2025, and $677000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Relay Therapeutics | 4.34 Bn | 4.34 Bn | - | 350,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 350,000.00 |
| Mar 31, 2026 | 3.00 Mn |
| Dec 31, 2025 | 7.00 Mn |
| Jun 30, 2025 | 677,000.00 |
| Mar 31, 2025 | 7.68 Mn |
| Mar 31, 2024 | 10.01 Mn |
| Dec 31, 2023 | -1,000.00 |
| Sep 30, 2023 | 25.20 Mn |
| Jun 30, 2023 | 119,000.00 |
| Mar 31, 2023 | 226,000.00 |
| Dec 31, 2022 | 253,000.00 |
| Sep 30, 2022 | 344,000.00 |
| Jun 30, 2022 | 365,000.00 |
| Mar 31, 2022 | 419,000.00 |
| Dec 31, 2021 | 567,000.00 |
| Sep 30, 2021 | 666,000.00 |
| Jun 30, 2021 | 844,000.00 |
| Mar 31, 2021 | 952,000.00 |